Author: Jasmine Riviere Marcelin, MD
Publication Alert: Structural Vulnerability among Patients with HIV and SARS-CoV-2 Co-Infection
Publication Alert: Structural Vulnerability among Patients with HIV and SARS-CoV-2 Co-Infection. This content was provided by Natasha Hongsermeier-Graves, MD/MPH student at UNMC College of Medicine/Harvard School of Public Health. She led a recently published study, collaborating with another UNMC medical student Rohan Khazanchi, and UNMC ID faculty Drs. Jasmine Marcelin and Nada Fadul.
Oct 19, 2021
Looking forward to meeting you at the #IDWeek2021 Virtual Career Fair!
Looking for your first position out of fellowship, or your next fulfilling position in your journey? The UNMC ID Division is a robust group comprised of 27 ID physicians, advanced practice providers, pharmacists, and clinical and research support staff. Looking forward to meeting you at the #IDWeek2021 Virtual Career Fair on 10/14/21!
Oct 11, 2021
Welcoming our new Infectious Diseases Pharmacy Resident: Jeremy Tigh PharmD
We are excited to welcome Jeremy Tigh PharmD as a new PGY-2 in our ID Pharmacy Residency Program! He’s the third ID Pharmacy resident we have had and a fantastic addition to our team! Read on to learn a little more about him…
Oct 5, 2021
High-level Review: Updated STI Guidelines Part 2
In July 2021 the Center for Disease Control and Prevention (CDC) released their sexually transmitted infections (STI) treatment guideline, an update from 2015.1 Below, senior ID fellow Dr. Jonathan Ryder highlights significant (but by no means comprehensive) changes in this new guideline that can be incorporated into clinical practice and some of the evidence supporting these changes. Part 2 – Bacterial Vaginosis, Trichomonas, Pelvic Inflammatory Disease
Sep 7, 2021
High-level Review: Updated STI Guidelines Part 1
In July 2021 the Center for Disease Control and Prevention (CDC) released their sexually transmitted infections (STI) treatment guideline, an update from 2015.1 Below, senior ID fellow Dr. Jonathan Ryder highlights significant (but by no means comprehensive) changes in this new guideline that can be incorporated into clinical practice and some of the evidence supporting these changes. Part 1 – Chlamydia, Gonorrhea, Mycoplasma genitalium
Sep 1, 2021
Diversity in Probiotics and Diversity in Clinical Trials: Opportunities for Improvement
This is a Journal Club review by Dr. Jasmine Marcelin of “A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization” (Rauseo, A. et al. Infection Control & Hospital Epidemiology, (2021).
Aug 17, 2021
Welcoming our New Infectious Diseases Fellows: Dr. Timothy McElroy
We are excited to welcome Dr. Timothy McElroy as a new fellow in our Infectious Diseases program! Read on to learn a little more about him…
Aug 10, 2021
Welcoming our New Infectious Diseases Fellows: Dr. Mackenzie Keintz
We are excited to welcome Dr. Mackenzie Keintz as a new fellow in our Infectious Diseases program! Read on to learn a little more about her…
Aug 4, 2021
Welcoming our New Infectious Diseases Fellows: Dr. Bryan Walker
We are excited to welcome Dr. Bryan Walker as a new fellow in our Infectious Diseases program! Read on to learn a little more about him…
Jul 27, 2021
UNMC ID is growing and we want you to join us!
Due to unprecedented growth and success, the Division of Infectious Diseases at the University of Nebraska Medical Center in Omaha, NE is recruiting for three (3) faculty members to join our team. Learn more…
Jul 22, 2021
Recent Comments